article thumbnail

Early experience with a novel transapical transcatheter aortic valve system in patients with severe aortic stenosis: a prospective, multicenter study

Frontiers in Cardiovascular Medicine

ObjectivesRegistered, prospective, multicenter study of the short-term clinical outcomes of a novel transcatheter aortic valve system (Xcor system, Saint Medical Technology, Inc., of patients showedmild paravalvular leakage, and all 125 (100%) patients were in New York Heart Association ClassII.

article thumbnail

Tricuspidization: repair of a quadricuspid aortic valve

Journal of Cardiothoracic Surgery

Quadricuspid aortic valve (QAV) is rare. However, to repair a quadricuspid aortic valve is not as easy to realize as in bicuspid aortic valve. The surgical design is crucial to rebuild the stable structure.

article thumbnail

The Society of Thoracic Surgeons Launches New Valve Surgery Risk Calculators

DAIC

Tricuspid Valve Repair Existing literature on national surgical outcomes of isolated tricuspid valve repair or replacement is based on data from over a decade ago and may not reflect current practice results. Analysis of 13,587 patients undergoing isolated tricuspid valve surgery from 2017 to 2023 revealed a 5.5%

TAVR 111
article thumbnail

Effect of Bicuspid Versus Tricuspid Aortic Valve Morphology on the Fate of the Ascending Aorta

Journal of the American Heart Association

BackgroundBicuspid aortic valves are associated with ascending aortic pathology, but their impact on longterm outcomes, including aortic growth and adverse events, remains unclear.Methods and ResultsThis prospective cohortstudy included adult patients undergoing aortic valve surgery or ascending aortic surgery at a single center (20072013).

article thumbnail

Outcomes Following Transcatheter Aortic Valve Replacement for Aortic Stenosis in Patients With Type 0 Bicuspid, Type 1 Bicuspid, and Tricuspid Aortic Valves

Circulation: Cardiovascular Interventions

BACKGROUND:Data concerning the outcomes of transcatheter aortic valve replacement in type 0 bicuspid aortic stenosis (AS) are scarce. Self-expanding transcatheter heart valves were used in the majority of patients (n=1160; 91.4%). In the matched population, differences in mortality (30 days: 4.2%

article thumbnail

Predictors of post-TAVI conduction abnormalities in patients with bicuspid aortic valves

Open Heart

Objectives This study evaluates predictors of conduction abnormalities (CA) following transcatheter aortic valve implantation (TAVI) in patients with bicuspid aortic valves (BAV). Predictors of CA are well established among patients with tricuspid aortic valves but not in those with BAV.

article thumbnail

Artificial intelligence-enabled phenotyping of patients with severe aortic stenosis: on the recovery of extra-aortic valve cardiac damage after transcatheter aortic valve replacement

Open Heart

Objective A novel artificial intelligence-based phenotyping approach to stratify patients with severe aortic stenosis (AS) prior to transcatheter aortic valve replacement (TAVR) has been proposed, based on echocardiographic and haemodynamic data. ±15.8 ±15.1 mm Hg, p value: 0.0079). to 84.7%) and 74.6% (95% CI 65.9%